Risperidone versus placebo for aggression following traumatic brain injury: a feasibility randomised controlled trial

OBJECTIVES: To conduct a feasibility randomised controlled trial of risperidone for the treatment of aggression in adults with traumatic brain injury (TBI). DESIGN: Multicentre, parallel design, placebo controlled (1:1 ratio) double-blind feasibility trial with an embedded process evaluation. No sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Deb, Shoumitro, Aimola, Lina, Leeson, Verity, Bodani, Mayur, Li, Lucia, Weaver, Tim, Sharp, David, Bassett, Paul, Crawford, Mike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Mental Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485257/
https://www.ncbi.nlm.nih.gov/pubmed/32912978
http://dx.doi.org/10.1136/bmjopen-2019-036300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485257/
https://www.ncbi.nlm.nih.gov/pubmed/32912978
http://dx.doi.org/10.1136/bmjopen-2019-036300

Ejemplares similares